SPRUTRITION美国云杉直播间，主播正在介绍SPRUTRITION槲皮素胶囊。直播间截图 "产品有什么作用？"记者在直播间留言后，主播并未直接回复，而是告诉记者，"往上面翻，刚刚有家人问过同样的问题，同样的情和况（情况）你看一下 有没有，有的话来跟我说"。记者向上翻动留言，发现有网友在直播间留言"什么结节都可以用吗？"记者注意到，该主播在评论区留言称"PPC每日晚饭后半 小时吃两颗即可，超过一厘米的早晚饭后各吃两颗~"。 也有网友留言咨询："我有甲状结（结节）和乳腺结（结节）可以用吗？"主播同样给出了肯定的答复。 记者点击商品链接发现，商家删除了原本产品介绍中所标示的"玻璃、混合、实性、囊、息、全身节节消"等直白的功效宣称，仅保留了两张暗示功效的宣传 图片，如"人生不纠'结'科学成分配比 小分子好吸收"。在消费者反馈的图片中，该图片右上角仍将产品表述为"云杉小分子PPC结节散胶囊"。 今年5月，新京报刊发《"美国原装、可消结节"胶囊调查：功效存疑，境外电商无此产品》的报道。记者调查发现，作为一款膳食营养补充剂产品，一款名 为SPRUTRITION槲皮素胶囊的"消结"产品存在多重问题：直播间"精准散结"等 ...

Core Viewpoint - Minsheng Health (301507) is actively expanding its business in the fields of treatment-type OTC drugs and medical aesthetics, demonstrating strategic determination and confidence in its growth prospects [1] Group 1: Business Development and Strategy - The company is focusing on the medical aesthetics business to respond to the transformation needs of pharmacy channels, promoting its products through model stores and counter placements in key pharmacies nationwide [1] - Minsheng Health's main product, 21 Jin Weita Multivitamin Tablets, is a non-prescription drug that is less affected by the challenges faced by pharmacy channels, with plans to expand its network and accelerate new product launches [2] - The company aims to become a benchmark enterprise in the vitamin and mineral sector, leveraging its strong R&D capabilities and product innovation to meet diverse health needs across different age groups [5] Group 2: Financial Performance - In Q1 2025, the company achieved revenue of 271 million yuan, a year-on-year increase of 15.70%, and a net profit of 61.12 million yuan, up 7.10% year-on-year, with total assets reaching 1.977 billion yuan, a growth of 13.32% [3] Group 3: Market Trends and Opportunities - The dietary supplement market in China has shown steady growth, with the market size increasing from 63.642 billion yuan in 2009 to 225.341 billion yuan in 2023, reflecting a compound annual growth rate (CAGR) of 8.47% from 2013 to 2023 [4] - The company is well-positioned to capitalize on the growing health awareness among the population and the potential for increased per capita consumption in the dietary supplement market [4] Group 4: Product and Brand Strategy - Minsheng Health has established a comprehensive health brand matrix, with "21 Jin Weita" leading in the vitamin and mineral sector, while also focusing on treatment-type OTC drugs and probiotics to meet specific health needs [5] - The company is committed to a brand rejuvenation strategy that targets all age groups, with a particular focus on the elderly demographic, offering products designed for joint treatment and anti-aging [6][7] Group 5: Technological Advancements - The company is advancing its digital and automated manufacturing capabilities, with ongoing projects aimed at enhancing production efficiency and quality control [7] - By implementing a standardized quality management system and strengthening supplier management, the company aims to ensure sustainable development and high-quality product offerings [7]